HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

In Brief

This article was originally published in The Rose Sheet

  • News

Executive Summary

P&G Discontinues Zirh Brand

You may also be interested in...



Arden Gives Facelift To Flagship Brand, Eyes Markets Abroad

Elizabeth Arden is modernizing its namesake cosmetics and fragrance brand to better position the range for international growth, the New York-based company announces.

Arden Gives Facelift To Flagship Brand, Eyes Markets Abroad

Elizabeth Arden is modernizing its namesake cosmetics and fragrance brand to better position the range for international growth, the New York-based company announces.

With Zirh Purchase P&G Adds Premium Skin Care To Men’s Grooming Portfolio

Procter & Gamble is serious about its goal of assembling "the world's premier male grooming company," scooping up high-end, "male-only" brand Zirh less than two weeks after its announced acquisition of The Art of Shaving

Table

View full table

Tags:
Latest Headlines

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

See All
UsernamePublicRestriction

Register

RS017704

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By